| River's Bend Health Services | |
| 960 S Rapids Rd, Manitowoc, Wisconsin 54220 | |
| (920) 684-1144 | |
| Name | River's Bend Health Services |
|---|---|
| Location | 960 S Rapids Rd, Manitowoc, Wisconsin |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 100 |
| Occupancy Rate | 67.5% |
| Medicare ID (CCN) | 525475 |
| Legal Business Name | Nsh Manitowoc Llc |
| Ownership Type | For Profit - Limited Liability Company |
| NPI Number | 1801967443 |
| Organization Name | ARBORS AT TOLEDO, INC. |
| Doing Business As | RIVER'S BEND HEALTH AND REHABILITATION CENTER |
| Address | 960 S Rapids Rd, Manitowoc, WI 54220 |
| Phone Number | 920-684-1144 |
News Archive
U.S. Department of Health and Human Services awarded two contracts today to help make vaccine available more quickly for seasonal flu outbreaks and pandemics. The contracts for advanced development of new types of vaccine and new ways to make flu vaccine known as next-generation recombinant influenza vaccine total $215 million.
Pharmaboardroom releases its new 98-page Mexico Healthcare and Life Sciences Report 2015. It offers companies, investors, policymakers, and stakeholders with an interest in healthcare, pharmaceuticals, or life sciences insights into the second largest pharma and healthcare market in Latin America, a country of over 122 million people.
Researchers have identified how the body's own immune system contributes to the nerve fiber damage caused by multiple sclerosis, a finding that can potentially aid earlier diagnosis and improved treatment for this chronic disease.
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that data from its first destination therapy clinical trial cohort, ENDURANCE, successfully demonstrated that the trial achieved the primary endpoint.
› Verified 3 days ago
| NPI Number | 1932627726 |
| Organization Name | NSH MANITOWOC LLC |
| Address | 960 S Rapids Rd, Manitowoc, WI 54220 |
| Phone Number | 920-684-1144 |
News Archive
U.S. Department of Health and Human Services awarded two contracts today to help make vaccine available more quickly for seasonal flu outbreaks and pandemics. The contracts for advanced development of new types of vaccine and new ways to make flu vaccine known as next-generation recombinant influenza vaccine total $215 million.
Pharmaboardroom releases its new 98-page Mexico Healthcare and Life Sciences Report 2015. It offers companies, investors, policymakers, and stakeholders with an interest in healthcare, pharmaceuticals, or life sciences insights into the second largest pharma and healthcare market in Latin America, a country of over 122 million people.
Researchers have identified how the body's own immune system contributes to the nerve fiber damage caused by multiple sclerosis, a finding that can potentially aid earlier diagnosis and improved treatment for this chronic disease.
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that data from its first destination therapy clinical trial cohort, ENDURANCE, successfully demonstrated that the trial achieved the primary endpoint.
› Verified 3 days ago
| NPI Number | 1962894295 |
| Organization Name | FMG SOUTH RAPIDS ROAD WISCONSIN LLC |
| Doing Business As | RIVER'S BEND HEALTH AND REHABILITATION CENTER |
| Address | 960 S Rapids Rd, Manitowoc, WI 54220 |
| Phone Number | 920-684-1144 |
News Archive
U.S. Department of Health and Human Services awarded two contracts today to help make vaccine available more quickly for seasonal flu outbreaks and pandemics. The contracts for advanced development of new types of vaccine and new ways to make flu vaccine known as next-generation recombinant influenza vaccine total $215 million.
Pharmaboardroom releases its new 98-page Mexico Healthcare and Life Sciences Report 2015. It offers companies, investors, policymakers, and stakeholders with an interest in healthcare, pharmaceuticals, or life sciences insights into the second largest pharma and healthcare market in Latin America, a country of over 122 million people.
Researchers have identified how the body's own immune system contributes to the nerve fiber damage caused by multiple sclerosis, a finding that can potentially aid earlier diagnosis and improved treatment for this chronic disease.
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that data from its first destination therapy clinical trial cohort, ENDURANCE, successfully demonstrated that the trial achieved the primary endpoint.
› Verified 3 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
U.S. Department of Health and Human Services awarded two contracts today to help make vaccine available more quickly for seasonal flu outbreaks and pandemics. The contracts for advanced development of new types of vaccine and new ways to make flu vaccine known as next-generation recombinant influenza vaccine total $215 million.
Pharmaboardroom releases its new 98-page Mexico Healthcare and Life Sciences Report 2015. It offers companies, investors, policymakers, and stakeholders with an interest in healthcare, pharmaceuticals, or life sciences insights into the second largest pharma and healthcare market in Latin America, a country of over 122 million people.
Researchers have identified how the body's own immune system contributes to the nerve fiber damage caused by multiple sclerosis, a finding that can potentially aid earlier diagnosis and improved treatment for this chronic disease.
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that data from its first destination therapy clinical trial cohort, ENDURANCE, successfully demonstrated that the trial achieved the primary endpoint.
› Verified 3 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 13.22 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 7.02 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 29.59 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.9 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.39 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 16.29 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 0.89 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 94.22 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 8.76 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 72.56 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.09 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 26.49 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 30 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 0.59 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 89.07 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 78.04 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 35.01 | 82.93 |
News Archive
U.S. Department of Health and Human Services awarded two contracts today to help make vaccine available more quickly for seasonal flu outbreaks and pandemics. The contracts for advanced development of new types of vaccine and new ways to make flu vaccine known as next-generation recombinant influenza vaccine total $215 million.
Pharmaboardroom releases its new 98-page Mexico Healthcare and Life Sciences Report 2015. It offers companies, investors, policymakers, and stakeholders with an interest in healthcare, pharmaceuticals, or life sciences insights into the second largest pharma and healthcare market in Latin America, a country of over 122 million people.
Researchers have identified how the body's own immune system contributes to the nerve fiber damage caused by multiple sclerosis, a finding that can potentially aid earlier diagnosis and improved treatment for this chronic disease.
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that data from its first destination therapy clinical trial cohort, ENDURANCE, successfully demonstrated that the trial achieved the primary endpoint.
› Verified 3 days ago
Bay At North Ridge Health And Rehabilitation Location: 1445 N 7th St, Manitowoc, Wisconsin 54220 Phone: (920) 682-0314 | |
Manitowoc Healthcare Center Location: 2021 S Alverno Rd, Manitowoc, Wisconsin 54220 Phone: (920) 683-4100 | |
River's Bend Health Services Location: 960 S Rapids Rd, Manitowoc, Wisconsin 54220 Phone: (920) 684-1144 | |
Shady Lane Nursing Care Center Location: 1235 S 24th St, Manitowoc, Wisconsin 54220 Phone: (920) 682-8254 | |
St Marys Home For The Aged Location: 1635 S 21st Street, Manitowoc, Wisconsin 54220 Phone: (920) 684-7171 |